Alnylam Pharmaceuticals, Inc.

Swiss National Bank ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

359,200

Value ($000)

142,836

Weight

0.1%

2013 Q4 - 2025 Q4 (28 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	142,836	0.1%	359,200	12/31/2025
2025 Q3	11/13/2025	171,365	0.1%	375,800	9/30/2025
2025 Q2	8/12/2025	128,414	0.1%	393,800	6/30/2025
2025 Q1	5/12/2025	98,341	0.1%	364,200	3/31/2025
2024 Q4	2/10/2025	85,323	0.1%	362,600	12/31/2024
2024 Q3	11/7/2024	103,246	0.1%	375,400	9/30/2024
2024 Q2	8/8/2024	90,979	0.1%	374,400	6/30/2024
2024 Q1	5/7/2024	56,178	0.0%	375,900	3/31/2024
2023 Q4	2/6/2024	74,803	0.1%	390,800	12/31/2023
2023 Q3	11/8/2023	70,946	0.1%	400,600	9/30/2023
2023 Q2	8/9/2023	85,017	0.1%	447,600	6/30/2023
2023 Q1	5/10/2023	97,816	0.1%	488,300	3/31/2023
2022 Q4	2/8/2023	115,997	0.1%	488,100	12/31/2022
2022 Q3	11/9/2022	104,806	0.1%	523,610	9/30/2022
2022 Q2	8/9/2022	76,048	0.1%	521,410	6/30/2022
2022 Q1	5/9/2022	84,586	0.0%	518,010	3/31/2022
2021 Q4	2/8/2022	76,601	0.0%	451,710	12/31/2021
2021 Q3	11/8/2021	87,723	0.1%	464,610	9/30/2021
2021 Q2	8/6/2021	80,846	0.0%	476,910	6/30/2021
2021 Q1	5/7/2021	63,087	0.0%	446,824	3/31/2021
2020 Q4	2/5/2021	56,930	0.0%	438,024	12/31/2020
2020 Q3	11/9/2020	65,072	0.1%	446,924	9/30/2020
2020 Q2	8/5/2020	65,972	0.1%	445,424	6/30/2020
2020 Q1	5/8/2020	47,091	0.0%	432,624	3/31/2020
2019 Q4	2/6/2020	40,381	0.0%	350,624	12/31/2019
2014 Q2	8/6/2014	3,841	0.0%	60,800	6/30/2014
2014 Q1	5/6/2014	4,263	0.0%	63,500	3/31/2014
2013 Q4	1/31/2014	3,159	0.0%	49,100	12/31/2013